Recent Developments in 3D Bio-Printing and Its Biomedical Applications (original) (raw)
Related papers
MRS Bulletin, 2015
Three-dimensional (3D) printing represents the direct fabrication of parts layer-by-layer, guided by digital information from a computer-aided design fi le without any part-specifi c tooling. Over the past three decades, a variety of 3D printing technologies have evolved that have transformed the idea of direct printing of parts for numerous applications. Threedimensional printing technology offers signifi cant advantages for biomedical devices and tissue engineering due to its ability to manufacture low-volume or one-of-a-kind parts on-demand based on patient-specifi c needs, at no additional cost for different designs that can vary from patient to patient, while also offering fl exibility in the starting materials. However, many concerns remain for widespread applications of 3D-printed biomaterials, including regulatory issues, a sterile environment for part fabrication, and the achievement of target material properties with the desired architecture. This article offers a broad overview of the fi eld of 3D-printed biomaterials along with a few specifi c applications to assist the reader in obtaining an understanding of the current state of the art and to encourage future scientifi c and technical contributions toward expanding the frontiers of 3D-printed biomaterials.
3D bioprinting for biomedical devices and tissue engineering: A review of recent trends and advances
3D printing, an additive manufacturing based technology for precise 3D construction, is currently widely employed to enhance applicability and function of cell laden scaffolds. Research on novel compatible biomaterials for bioprinting exhibiting fast crosslinking properties is an essential prerequisite toward advancing 3D printing applications in tissue engineering. Printability to improve fabrication process and cell encapsulation are two of the main factors to be considered in development of 3D bioprinting. Other important factors include but are not limited to printing fidelity, stability, crosslinking time, biocom-patibility, cell encapsulation and proliferation, shear-thinning properties, and mechanical properties such as mechanical strength and elasticity. In this review, we recite recent promising advances in bioink development as well as bioprinting methods. Also, an effort has been made to include studies with diverse types of crosslinking methods such as photo, chemical and ultraviolet (UV). We also propose the challenges and future outlook of 3D bioprinting application in medical sciences and discuss the high performance bioinks.
Polymeric biomaterials for 3D printing in medicine: An overview
Annals of 3D Printed Medicine, 2021
Three-dimensional (3D) printing is becoming a booming technology to fabricate scaffolds, orthoses, and prosthetic devices for tissue engineering, regenerative medicine, and rehabilitation for patients with disabling neurological diseases (such as amyotrophic lateral sclerosis, traumatic brain injuries, and spinal cord injuries). This is due to the potential of 3D printing to provide patient-specific designs, high structural complexity, and rapid on-demand fabrication at a low-cost. However, one of the major bottlenecks that limits the widespread acceptance of 3D printing for biomedical manufacturing is the lack of polymers, biomaterials, hydrogels, and bioinks functional for 3D printing, biocompatible, and more performing from the biomechanical point of view to meet the different needs. As a matter of fact the field is still struggling with processing of such materials into self-supporting devices with tunable biomechanics, optimal structures, degradation, and bioactivity. Here, will be highlighted all recent advances that have been made in the field of 3D printing in biomedicine, analyzing the polymers, hydrogels, and bioinks, according to their printability, ease of processability, cost, and properties such as mechanics, biocompatibility, and degradation rate. Finally, future considerations for 3D bio-fabrication will be discussed.
Toward Biomimetic Scaffolds for Tissue Engineering: 3D Printing Techniques in Regenerative Medicine
Frontiers in Bioengineering and Biotechnology, 2020
Three-dimensional (3D) printing technology allows fabricating complex and precise structures by stacking materials layer by layer. The fabrication method has a strong potential in the regenerative medicine field to produce customizable and defect-fillable scaffolds for tissue regeneration. Plus, biocompatible materials, bioactive molecules, and cells can be printed together or separately to enhance scaffolds, which can save patients who suffer from shortage of transplantable organs. There are various 3D printing techniques that depend on the types of materials, or inks, used. Here, different types of organs (bone, cartilage, heart valve, liver, and skin) that are aided by 3D printed scaffolds and printing methods that are applied in the biomedical fields are reviewed.
Advances in 3D Printing for Tissue Engineering
Materials, 2021
Tissue engineering (TE) scaffolds have enormous significance for the possibility of regeneration of complex tissue structures or even whole organs. Three-dimensional (3D) printing techniques allow fabricating TE scaffolds, having an extremely complex structure, in a repeatable and precise manner. Moreover, they enable the easy application of computer-assisted methods to TE scaffold design. The latest additive manufacturing techniques open up opportunities not otherwise available. This study aimed to summarize the state-of-art field of 3D printing techniques in applications for tissue engineering with a focus on the latest advancements. The following topics are discussed: systematics of the available 3D printing techniques applied for TE scaffold fabrication; overview of 3D printable biomaterials and advancements in 3D-printing-assisted tissue engineering.
Designing Biomaterials for 3D Printing
Three-dimensional (3D) printing is becoming an increasingly common technique to fabricate scaffolds and devices for tissue engineering applications. This is due to the potential of 3D printing to provide patient-specific designs, high structural complexity, rapid on-demand fabrication at a low-cost. One of the major bottlenecks that limits the widespread acceptance of 3D printing in biomanufacturing is the lack of diversity in "biomaterial inks". Printability of a biomaterial is determined by the printing technique. Although a wide range of biomaterial inks including polymers, ceramics, hydrogels and composites have been developed, the field is still struggling with processing of these materials into self-supporting devices with tunable mechanics, degradation, and bioactivity. This review aims to highlight the past and recent advances in biomaterial ink development and design considerations moving forward. A brief overview of 3D printing technologies focusing on ink design parameters is also included.
An Overview on Materials and Techniques in 3D Bioprinting Toward Biomedical Application
Engineered Regeneration, 2021
Three-dimensional (3D) bioprinting, an additive manufacturing based technique of biomaterials fabrication, is an innovative and auspicious strategy in medical and pharmaceutical fields. The ability of producing regenerative tissues and organs has made this technology a pioneer to the creation of artificial multi-cellular tissues/organs. A broad variety of biomaterials is currently being utilized in 3D bioprinting as well as multiple techniques employed by researchers. In this review, we demonstrate the most common and novel biomaterials in 3D bioprinting technology further with introducing the related techniques that are commonly taking into account by researchers. In addition, an attempt has been accomplished to hand over the most relevant application of 3D bioprinting techniques such as tissue regeneration, cancer investigations, etc. by presenting the most important works. The main aim of this review paper is to emphasis on strengths and limitations of existence biomaterials and 3D bioprinting techniques in order to carry out a comparison through them.
Advanced 3D-Printed Systems and Nanosystems for Drug Delivery and Tissue Engineering
Advanced 3D-Printed Systems and Nanosystems for Drug Delivery and Tissue Engineering A volume in Woodhead Publishing Series in Biomaterials Book , 2020
Mechanical properties of three-dimensional (3D) scaffolds are critical for their biomedical applications. Several methods have been utilized to augment the mechanical properties of the 3D-printed scaffolds. The current chapter focuses on potential techniques that are applicable for the augmentation of mechanical properties of 3D-printed scaffolds. Particularly, the utilization of inorganic materials to reinforce 3D-printed scaffolds as reported in the current literature is highlighted. The overall aim is to provide a relatively exhaustive account of the various inorganic materials applied for 3D printing innovation. Different sources were reviewed in this chapter involving 3D structures for industrial applications and 3D-printed scaffolds for biomedical applications. Various inorganic materials were reported, including metal composites, metal oxides, and ceramic materials. Therefore, in this chapter, the most relevant materials that have been reported for mechanical augmentation of 3D-printed scaffolds are reviewed.
3D Printing: Applications in Tissue Engineering, Medical Devices, and Drug Delivery
AAPS PharmSciTech, 2022
The gemstone of 3-dimensional (3D) printing shines up from the pyramid of additive manufacturing. Three-dimensional bioprinting technology has been predicted to be a game-changing breakthrough in the pharmaceutical industry since the last decade. It is fast evolving and finds its seats in a variety of domains, including aviation, defense, automobiles, replacement components, architecture, movies, musical instruments, forensic, dentistry, audiology, prosthetics, surgery, food, and fashion industry. In recent years, this miraculous manufacturing technology has become increasingly relevant for pharmaceutical purposes. Computer-aided drug (CAD) model will be developed by computer software and fed into bioprinters. Based on material inputs, the printers will recognize and produce the model scaffold. Techniques including stereolithography, selective laser sintering, selective laser melting, material extrusion, material jetting, inkjet-based, fused deposition modelling, binder deposition, ...
Three-dimensional (3-D) cell printing, which can accurately deposit cells, biomaterial scaffolds and growth factors in precisely defined spatial patterns to form biomimetic tissue structures, has emerged as a powerful enabling technology to create live tissue and organ structures for drug discovery and tissue engineering applications. Unlike traditional 3-D printing that uses metals, plastics and polymers as the printing materials, cell printing has to be compatible with living cells and biological matrix. It is also required that the printing process preserves the biological functions of the cells and extracellular matrix, and to mimic the cell-matrix architectures and mechanical properties of the native tissues. Therefore, there are significant challenges in order to translate the technologies of traditional 3-D printing to cell printing, and ultimately achieve functional outcomes in the printed tissues. So it is essential to develop new technologies specially designed for cell printing and in-depth basic research in the bioprinted tissues, such as developing novel biomaterials specifically for cell printing applications, understanding the complex cell-matrix remodeling for the desired mechanical properties and functional outcomes, establishing proper vascular perfusion in bioprinted tissues, etc. In recent years, many exciting research progresses have been made in the 3-D cell printing technology and its application in engineering live tissue constructs. This review paper summarized the current development in 3-D cell printing technologies; focus on the outcomes of the live printed tissues and their potential applications in drug discovery and regenerative medicine. Current challenges and limitations are highlighted, and future directions of 3-D cell printing technology are also discussed.